I am Nicoletta Machin, DO, MS, an Assistant Professor in the Division of Classical Hematology at the University of Pittsburgh School of Medicine and a faculty hematologist at the Hemophilia Center of Western Pennsylvania (UPMC). I received my Doctor of Osteopathic Medicine degree from the University of New England College of Osteopathic Medicine and completed internal medicine residency followed by hematology/oncology fellowship training at UPMC, with focused training in benign and classical hematology. My clinical and research work centers on inherited bleeding disorders, including von Willebrand disease and hemophilia, with particular emphasis on women’s health, heavy menstrual bleeding, pregnancy-associated bleeding, postpartum hemorrhage, and iron deficiency. I lead and collaborate on multiple investigator-initiated clinical trials and registry-based studies evaluating bleeding phenotype modifiers, treatment strategies, and iron repletion in patients with bleeding disorders. I am actively involved in medical education and fellowship leadership and am a member of the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH).
I am Nicoletta Machin, DO, MS, an Assistant Professor in the Division of Classical Hematology at the University of Pittsburgh School of Medicine and a faculty hematologist at the Hemophilia Center of Western Pennsylvania (UPMC). I received my Doctor of Osteopathic Medicine degree from the University of New England College of Osteopathic Medicine and completed internal medicine residency followed by hematology/oncology fellowship training at UPMC, with focused training in benign and classical hematology. My clinical and research work centers on inherited bleeding disorders, including von Willebrand disease and hemophilia, with particular emphasis on women’s health, heavy menstrual bleeding, pregnancy-associated bleeding, postpartum hemorrhage, and iron deficiency. I lead and collaborate on multiple investigator-initiated clinical trials and registry-based studies evaluating bleeding phenotype modifiers, treatment strategies, and iron repletion in patients with bleeding disorders. I am actively involved in medical education and fellowship leadership and am a member of the American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH).